Quick Read
-
SCHD packs 42% of its $71.6 billion into just 10 stocks, running roughly 12 points above the concentration typical of large-cap dividend peers.
-
ConocoPhillips surged 29% year to date while Altria’s 5.8% yield proves SCHD’s dividend-quality screen still delivers on its income promise.
-
SCHD’s quarterly payout doubled from $0.12 to $0.26 since 2011, making it a strong income sleeve for retirees but a risky standalone core holding.
-
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Schwab U.S. Dividend Equity ETF didn’t make the cut. Grab the names FREE today.
Most Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) owners assume they are buying broad market diversification. The latest Schwab fact sheet tells a different story. SCHD’s top 10 holdings now account for 41% of the fund’s $71.6 billion in net assets, well above the roughly 30% top-10 weight typical of large-cap dividend peers. SCHD still earns its reputation as a low-cost income workhorse, but the concentration question changes who should treat it as a core holding versus a sleeve.
What SCHD is built to do
SCHD tracks the Dow Jones U.S. Dividend 100 Index, which screens for cash flow to debt, return on equity, dividend yield, and five-year dividend growth, then reconstitutes once a year. The screen is the point. It filters out high yielders that cannot sustain payouts and tilts the portfolio toward established cash generators. The return engine is plain. You get dividends from roughly 100 quality-screened companies plus whatever capital appreciation those businesses produce. No options overlay, no leverage, no derivatives.
The expense ratio of 0.06% puts SCHD in the cheapest tier of any dividend ETF, and the trailing yield sits near 3.9% based on recent quarterly distributions, well above the S&P 500’s roughly 1.3%.
Does the strategy deliver?
SCHD’s price returned 26% over the past year and 19% year to date through early June. The five-year price gain of 50% trails the S&P 500’s roughly 90% over the same window, which is the honest tradeoff: the dividend-quality screen kept SCHD out of the mega-cap tech names that drove most of the index’s gains. Add a decade of compounded dividends to the 229% ten-year price gain and the absolute result still works for income investors.
The top holdings explain the recent rebound. ConocoPhillips (NYSE:COP) is up 29% year to date, Chevron (NYSE:CVX) is up 27%, and Altria (NYSE:MO) is up 26%. Altria’s 5.8% yield and Bristol-Myers Squibb’s 4.4% yield are doing exactly what the strategy promises.